Novo Holdings and TA Associates (“TA”), announce that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites (“the Company”), an international medical devices company that engineers, manufactures and markets leading products for use in infection management in bone and soft tissue. As part of the transaction TA, Biocomposites’ majority shareholder since 2017, will reinvest in the Company alongside new investor Novo Holdings and Biocomposites’ management. The transaction gives TA and Novo Holdings shared control of Biocomposites.
Read the full article: Novo Holdings and TA Associates Partner with Biocomposites to Drive Next Chapter of Its Growth //
Source: https://www.prnewswire.com/news-releases/novo-holdings-and-ta-associates-partner-with-biocomposites-to-drive-next-chapter-of-its-growth-302389588.html